![](/img/cover-not-exists.png)
388 Ixekizumab, a novel anti-IL-17A antibody, exhibits low immunogenicity during long-term treatment in patients with psoriasis
Blauvelt, A., Langley, R., Leonardi, C., Gordon, K., Luger, T., Ohtsuki, M., Nickoloff, B., Kerr, L., Mallbris, L., Reich, K.Volume:
136
Language:
english
Journal:
Journal of Investigative Dermatology
DOI:
10.1016/j.jid.2016.06.408
Date:
September, 2016
File:
PDF, 60 KB
english, 2016